Your browser doesn't support javascript.
loading
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
Wistuba-Hamprecht, Kilian; Martens, Alexander; Heubach, Florian; Romano, Emanuela; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael; Wong, Phillip; Mallardo, Domenico; Schilling, Bastian; Di Giacomo, Anna Maria; Khammari, Amir; Dreno, Brigitte; Maio, Michele; Schadendorf, Dirk; Ascierto, Paolo A; Wolchok, Jedd D; Blank, Christian U; Garbe, Claus; Pawelec, Graham; Weide, Benjamin.
Affiliation
  • Wistuba-Hamprecht K; Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany. Electronic address: kilian.wistuba-hamprecht@uni-tuebingen.de.
  • Martens A; Department of Dermatology, University Medical Center, Tübingen, Germany; Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
  • Heubach F; Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
  • Romano E; Department of Oncology, Immunotherapy Unit, INSERM U932, Institut Curie, Paris, France.
  • Geukes Foppen M; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Yuan J; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Postow M; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
  • Wong P; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mallardo D; Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Schilling B; Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Di Giacomo AM; Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy.
  • Khammari A; Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France.
  • Dreno B; Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes, France.
  • Maio M; Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy.
  • Schadendorf D; Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Ascierto PA; Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
  • Blank CU; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Garbe C; Department of Dermatology, University Medical Center, Tübingen, Germany.
  • Pawelec G; Department of Internal Medicine II, University Medical Center, Tübingen, Germany; School of Science and Technology, College of Arts and Science, Nottingham Trent University, Nottingham, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Weide B; Department of Dermatology, University Medical Center, Tübingen, Germany.
Eur J Cancer ; 73: 61-70, 2017 03.
Article in En | MEDLINE | ID: mdl-28167454

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Biomarkers, Tumor / CD8-Positive T-Lymphocytes / Immunologic Memory / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Biomarkers, Tumor / CD8-Positive T-Lymphocytes / Immunologic Memory / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2017 Document type: Article